[Report of a trial with Pervincamine Forte Retard in 50 cases of various otological disorders].
D000293:Adolescent; D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D004427:Ear Diseases / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000860:Hypoxia / Q000517:prevention & control; D007511:Ischemia / Q000517:prevention & control; D008297:Male; D008875:Middle Aged; D014652:Vascular Diseases / Q000188:drug therapy*; D014748:Vinca Alkaloids / Q000008:administration & dosage / Q000627:therapeutic use*
D014748:Vinca Alkaloids
Compte rendu d'expérimentation du produit Pervincamine Forte Retard dans 50 cas de troubles otologiques divers.